HUT72490A - Use of 2-chloro-1-[[4-[(2,6-dichlorophenoxy)methyl]-phenyl]methoxy]-4-methoxy-benzene for producing pharmaceutical preparations using for the selective treatment of enteroviral infections in humans - Google Patents
Use of 2-chloro-1-[[4-[(2,6-dichlorophenoxy)methyl]-phenyl]methoxy]-4-methoxy-benzene for producing pharmaceutical preparations using for the selective treatment of enteroviral infections in humans Download PDFInfo
- Publication number
- HUT72490A HUT72490A HU9502494A HU9502494A HUT72490A HU T72490 A HUT72490 A HU T72490A HU 9502494 A HU9502494 A HU 9502494A HU 9502494 A HU9502494 A HU 9502494A HU T72490 A HUT72490 A HU T72490A
- Authority
- HU
- Hungary
- Prior art keywords
- compound
- formula
- enteroviral
- methoxy
- humans
- Prior art date
Links
- XXMDDBVNWRWNCW-UHFFFAOYSA-N COc(cc1Cl)ccc1OCc1ccc(COc(c(Cl)ccc2)c2Cl)cc1 Chemical compound COc(cc1Cl)ccc1OCc1ccc(COc(c(Cl)ccc2)c2Cl)cc1 XXMDDBVNWRWNCW-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Epoxy Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2352793A | 1993-02-26 | 1993-02-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HU9502494D0 HU9502494D0 (en) | 1995-10-30 |
| HUT72490A true HUT72490A (en) | 1996-05-28 |
Family
ID=21815649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9502494A HUT72490A (en) | 1993-02-26 | 1994-02-23 | Use of 2-chloro-1-[[4-[(2,6-dichlorophenoxy)methyl]-phenyl]methoxy]-4-methoxy-benzene for producing pharmaceutical preparations using for the selective treatment of enteroviral infections in humans |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0686032A1 (cs) |
| JP (1) | JPH08507062A (cs) |
| AU (1) | AU691490B2 (cs) |
| CA (1) | CA2156916A1 (cs) |
| FI (1) | FI953980L (cs) |
| HU (1) | HUT72490A (cs) |
| IL (1) | IL108749A0 (cs) |
| MX (1) | MXPA94001379A (cs) |
| NZ (1) | NZ262794A (cs) |
| TW (1) | TW284686B (cs) |
| WO (1) | WO1994018960A1 (cs) |
| ZA (1) | ZA941244B (cs) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020070390A1 (en) | 2018-10-03 | 2020-04-09 | Jyväskylän Yliopisto | Vemurafenib and salts thereof for use in the treatment of enteroviral infections |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE8412799U1 (de) * | 1984-04-26 | 1984-10-31 | William Prym-Werke Kg, 5190 Stolberg | SB-Verkaufsvorrichtung mit einer als Blisterpackung ausgebildeten Verkaufspackung fuer Fadenlegewerkzeuge wie Stricknadeln |
| CZ279793A3 (en) * | 1991-06-19 | 1994-05-18 | Schering Corp | Orally active antiviral compounds |
-
1994
- 1994-02-23 ZA ZA941244A patent/ZA941244B/xx unknown
- 1994-02-23 CA CA002156916A patent/CA2156916A1/en not_active Abandoned
- 1994-02-23 JP JP6519068A patent/JPH08507062A/ja active Pending
- 1994-02-23 AU AU62679/94A patent/AU691490B2/en not_active Ceased
- 1994-02-23 WO PCT/US1994/001605 patent/WO1994018960A1/en not_active Ceased
- 1994-02-23 HU HU9502494A patent/HUT72490A/hu unknown
- 1994-02-23 IL IL10874994A patent/IL108749A0/xx unknown
- 1994-02-23 FI FI953980A patent/FI953980L/fi unknown
- 1994-02-23 MX MXPA94001379A patent/MXPA94001379A/es not_active Application Discontinuation
- 1994-02-23 EP EP94910114A patent/EP0686032A1/en not_active Ceased
- 1994-02-23 NZ NZ262794A patent/NZ262794A/en unknown
- 1994-02-24 TW TW083101586A patent/TW284686B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| FI953980A7 (fi) | 1995-08-24 |
| CA2156916A1 (en) | 1994-09-01 |
| MXPA94001379A (es) | 2011-09-26 |
| AU6267994A (en) | 1994-09-14 |
| NZ262794A (en) | 1997-03-24 |
| IL108749A0 (en) | 1994-05-30 |
| WO1994018960A1 (en) | 1994-09-01 |
| TW284686B (cs) | 1996-09-01 |
| AU691490B2 (en) | 1998-05-21 |
| EP0686032A1 (en) | 1995-12-13 |
| ZA941244B (en) | 1994-08-23 |
| FI953980A0 (fi) | 1995-08-24 |
| JPH08507062A (ja) | 1996-07-30 |
| FI953980L (fi) | 1995-08-24 |
| HU9502494D0 (en) | 1995-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lott et al. | Atypical hand-foot-and-mouth disease associated with coxsackievirus A6 infection | |
| Roos | Encephalitis | |
| Englund et al. | Herpes simplex virus resistant to acyclovir: a study in a tertiary care center | |
| Rotbart | Enteroviral infections of the central nervous system | |
| Slots et al. | Bacterial and viral pathogens in saliva: disease relationship and infectious risk | |
| Rotbart | Antiviral therapy for enteroviruses and rhinoviruses | |
| Bryant et al. | Neonatal coxsackie B virus infection—a treatable disease? | |
| Jackson et al. | Management of influenza: use of new antivirals and resistance in perspective | |
| Florea et al. | Pleconaril, a novel antipicornaviral agent | |
| Woods et al. | In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug | |
| Romero | Diagnosis and management of enteroviral infections of the central nervous system | |
| Chonmaitree et al. | Respiratory infections | |
| Richardson Jr et al. | “Hand, foot, and mouth disease” in children: An epidemic associated with Coxsackie virus A-16 | |
| Chambon et al. | An outbreak due to echovirus type 30 in a neonatal unit in France in 1997: usefulness of PCR diagnosis | |
| Grist et al. | General pathogenicity and epidemiology | |
| Ma et al. | Long-term persistence of viral RNA and inflammation in the CNS of macaques exposed to aerosolized Venezuelan equine encephalitis virus | |
| HUT72490A (en) | Use of 2-chloro-1-[[4-[(2,6-dichlorophenoxy)methyl]-phenyl]methoxy]-4-methoxy-benzene for producing pharmaceutical preparations using for the selective treatment of enteroviral infections in humans | |
| Retalis et al. | The spectrum of adult adenovirus pneumonia | |
| JPH0713019B2 (ja) | １―β―Ｄ―リボフラノシル―１，２，４―トリアゾール―３―カルボキサミドを活性成分とするヒトのウィルス性疾患治療用医薬組成物 | |
| Afrose | Coxsackie virus: the hand, foot, mouth disease (hfmd) | |
| Miller | Viral infections in the immunocompetent patient | |
| Keyserling | Other viral agents of perinatal importance: varicella, parvovirus, respiratory syncytial virus, and enterovirus | |
| Togo et al. | Antiviral effect of 3, 4-dihydro-1-isoquinolineacetamide hydrochloride in experimental human rhinovirus infection | |
| CN113288896A (zh) | 槐定碱在制备抗疱疹病毒的药物中的用途 | |
| Chang et al. | Enterovirus 71 encephalitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DFC4 | Cancellation of temporary protection due to refusal |